Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study. (Record no. 29289625)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02132 a2200601 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518020959.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201904s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1756-1833 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1136/bmj.l67 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gottenberg, Jacques-Eric |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190403 |
| 245 00 - TITLE STATEMENT | |
| Title | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | BMJ (Clinical research ed.) |
| Date of publication, distribution, etc. | Jan 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | l67 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Comparative Study; Journal Article; Multicenter Study |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Abatacept |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antirheumatic Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Arthritis, Rheumatoid |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biological Factors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cohort Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Monitoring |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | France |
| General subdivision | epidemiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Outcome Assessment, Health Care |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rituximab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Analysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tumor Necrosis Factor-alpha |
| General subdivision | antagonists & inhibitors |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Morel, Jacques |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Perrodeau, Elodie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bardin, Thomas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Combe, Bernard |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dougados, Maxime |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Flipo, Rene-Marc |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Saraux, Alain |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schaeverbeke, Thierry |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sibilia, Jean |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Soubrier, Martin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vittecoq, Olivier |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Baron, Gabriel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Constantin, Arnaud |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ravaud, Philippe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mariette, Xavier |
| 773 0# - HOST ITEM ENTRY | |
| Title | BMJ (Clinical research ed.) |
| Related parts | vol. 364 |
| -- | p. l67 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1136/bmj.l67">https://doi.org/10.1136/bmj.l67</a> |
| Public note | Available from publisher's website |
No items available.